Talent Biotech's Acquisition

Talent Biotech was acquired by Kalytera Therapeutics on January 13, 2017.

Talent Biotech is a developer of proprietary cannabidiol (CBD) therapeutics to treat Graft versus Host Disease, an orphan condition that can arise following stem cell or bone marrow transplants.…

Articles about Talent Biotech's Acquisition: